ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Glycochenodeoxycholic Acid

Also known as: GCDCA, Glycochenodeoxycholic Acid, Glycochenodeoxycholic Acid Bile Salt

Overview

Glycochenodeoxycholic acid (GCDCA) is a bile acid conjugate synthesized in the liver from glycine and chenodeoxycholic acid. It is classified as a secondary bile acid, formed in the intestine through the action of gut bacteria on primary bile acids. GCDCA is essential for the emulsification and absorption of dietary fats and fat-soluble vitamins, thereby aiding lipid digestion. This compound is stored in the gallbladder and released into the intestine when needed for digestion. Recent research has highlighted its potential as a biomarker for gallstone disease (GSD) and metabolic disorders, as its serum levels exhibit significant changes in affected individuals. Characterized by its amphipathic properties, GCDCA effectively solubilizes dietary lipids and has been extensively studied in systematic reviews that outline its physiological and pathological relevance.

Benefits

GCDCA has been demonstrated to have important health implications, particularly in its role as a diagnostic marker. Studies have shown that serum levels of GCDCA are notably reduced in patients with gallstone disease—one meta-analysis indicated a mean difference of -13.82 mmol/L when compared to healthy controls (95% CI = -21.86; -5.78). While serum GCDCA levels in metabolic dysfunction-associated steatohepatitis (MASLD) do not differ significantly from healthy individuals, the overall bile acid profile is altered, suggesting a connection to metabolic dysfunction. Monitoring of GCDCA levels is particularly beneficial for individuals with GSD and MASLD as a potential diagnostic tool, although further validation is required to confirm these findings.

How it works

GCDCA interacts primarily through bile acid signaling pathways, including the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5). These receptors are instrumental in regulating lipid metabolism, glucose homeostasis, and energy balance, particularly affecting gastrointestinal functions. GCDCA promotes the emulsification of dietary fats in the intestine, facilitating their absorption. After its physiological function, it is reabsorbed in the ileum and recycled back to the liver via enterohepatic circulation, ensuring its availability and efficacy in various metabolic processes.

Side effects

GCDCA is generally recognized as safe, attributed to its natural occurrence within the human body. Documented adverse effects are rare, mainly because it is not typically used as a therapeutic supplement. Available literature shows no significant common or uncommon side effects associated with GCDCA administration. However, caution is warranted for individuals suffering from severe liver or gallbladder diseases, as such conditions might affect bile acid metabolism and its resulting effects. Potential drug interactions may arise with medications that influence bile acid transport, though specific interactions remain largely undocumented. Overall, GCDCA is considered safe, yet monitoring may be prudent in certain populations due to variations in individual health conditions.

Dosage

GCDCA is not commonly administered as a dietary supplement; therefore, specific dosage recommendations are not applicable. Its natural role is primarily as a component of bile for digestive processes and as a diagnostic biomarker. Current research has not established standardized dosages for therapeutic use; thus, further clinical studies are necessary to identify effective dosing regimens should GCDCA be explored for therapeutic applications. Its absorption and optimal bioavailability depend on the body's natural enterohepatic circulation processes, which function without the need for external supplementation.

FAQs

Is GCDCA available as a supplement?

No, GCDCA is not commonly used as a dietary supplement. It primarily serves as a biomarker in clinical settings.

Is GCDCA safe?

Yes, GCDCA is generally considered safe as a naturally occurring bile acid, though caution is advised in individuals with specific liver or gallbladder conditions.

What are the expected benefits of GCDCA levels?

Altered GCDCA levels can aid in the diagnosis of gallstone disease and metabolic disorders, serving as potential biomarkers.

Can GCDCA be taken at any time?

GCDCA is produced naturally in the body; it is not administered like a supplement, hence timing for administration is not applicable.

Are there any misconceptions about GCDCA?

A common misconception is that GCDCA is a supplement. It is actually a naturally occurring bile acid with diagnostic applications.

Supplements Containing Glycochenodeoxycholic Acid

Bile Acid Factors by Jarrow Formulas
63

Bile Acid Factors

Jarrow Formulas

Score: 63/100
Bile Acid Factors by Jarrow Formulas
65

Bile Acid Factors

Jarrow Formulas

Score: 65/100
Bile Acid Factors by Jarrow Formulas
68

Bile Acid Factors

Jarrow Formulas

Score: 68/100